Document Magnitude and Timing for Pain Relief of Topical Cream

Natural Immune Systems Inc1 site in 1 country12 target enrollmentAugust 1, 2021

ConditionsChronic Pain

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Pain
Sponsor: Natural Immune Systems Inc
Enrollment: 12
Locations: 1
Primary Endpoint: Change in degree of pain
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To perform a clinical proof-of-concept study on a novel topical formula for pain relief.

Detailed Description

An open-label study where each participant will be involved in the study for 4 weeks. During the study participants will use the topical cream 1-2 times daily on the anatomical area(s) causing the most pain.

Registry

clinicaltrials.gov

Start Date

August 1, 2021

End Date

May 1, 2022

Last Updated

3 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Natural Immune Systems Inc

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•BMI between 18.5 and 34.9 kg/m2 (inclusive)
•Chronic joint/muscle related pain for at least past 6 months
•Experiencing chronic pain in at least one specific anatomical area for more than 6 months.

Exclusion Criteria

•Cancer during past 12 months
•Chemotherapy during past 12 months
•Currently taking prescription pain medications
•Getting regular joint injections (such as cortisone shots);
•Immunization during last month
•Participation in another clinical trial study during this trial, involving an investigational product or lifestyle change
•Regularly experiencing headaches, including migraines
•Serious active illness within past 6 months
•Significant active uncontrolled illness (such as lymphoma, liver disease, kidney failure, heart failure).
•Skin allergies related to ingredients in test product.